Li, Y., Xu-Monette, Z. Y., Abramson, J., Sohani, A. R., Bhagat, G., Tzankov, A., … Young, K. H. (2023). EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv, 7(7), 1308–1311. https://doi.org/10.1182/bloodadvances.2022008550

Li, Yong, Zijun Y. Xu-Monette, Jeremy Abramson, Aliyah R. Sohani, Govind Bhagat, Alexandar Tzankov, Carlo Visco, et al. “EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential.” Blood Adv 7, no. 7 (April 11, 2023): 1308–11. https://doi.org/10.1182/bloodadvances.2022008550.

Li Y, Xu-Monette ZY, Abramson J, Sohani AR, Bhagat G, Tzankov A, et al. EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023 Apr 11;7(7):1308–11.

Li, Yong, et al. “EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential.” Blood Adv, vol. 7, no. 7, Apr. 2023, pp. 1308–11. Pubmed, doi:10.1182/bloodadvances.2022008550.

Li Y, Xu-Monette ZY, Abramson J, Sohani AR, Bhagat G, Tzankov A, Visco C, Zhang S, Dybkaer K, Pan Z, Xu M, Tam W, Zu Y, Hsi ED, Hagemeister FB, Go H, van Krieken JH, Winter JN, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Wang Y, Zhang M, Young KH. EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023 Apr 11;7(7):1308–1311.